Clinical Trial Update: Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Metvix Natural Daylight photodynamic therapy to conventional Metvix PDT in patients with actinic keratoses; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Metvix (methyl aminolevulinate)
• Metvix Natural Daylight Photodynamic Therapy
• Metvix Photodynamic Therapy (methyl aminolevulinate)

Snippet

Sponsor: Galderma R&D | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED | Results posted: 2016-04-18